nodes	percent_of_prediction	percent_of_DWPC	metapath
Timolol—ABCB1—lung cancer	0.25	1	CbGaD
Timolol—CYP2C19—Gefitinib—lung cancer	0.0429	0.0923	CbGbCtD
Timolol—CYP2C19—Teniposide—lung cancer	0.0416	0.0895	CbGbCtD
Timolol—ABCB1—Topotecan—lung cancer	0.0379	0.0814	CbGbCtD
Timolol—ABCB1—Gefitinib—lung cancer	0.0346	0.0744	CbGbCtD
Timolol—CYP2D6—Gefitinib—lung cancer	0.0326	0.0701	CbGbCtD
Timolol—ABCB1—Vinorelbine—lung cancer	0.0267	0.0573	CbGbCtD
Timolol—CYP2D6—Vinorelbine—lung cancer	0.0251	0.054	CbGbCtD
Timolol—ABCB1—Crizotinib—lung cancer	0.0212	0.0456	CbGbCtD
Timolol—ABCB1—Gemcitabine—lung cancer	0.0207	0.0446	CbGbCtD
Timolol—ABCB1—Erlotinib—lung cancer	0.0205	0.044	CbGbCtD
Timolol—CYP2D6—Erlotinib—lung cancer	0.0193	0.0415	CbGbCtD
Timolol—ABCB1—Paclitaxel—lung cancer	0.0187	0.0403	CbGbCtD
Timolol—ABCB1—Irinotecan—lung cancer	0.0185	0.0397	CbGbCtD
Timolol—ABCB1—Vinblastine—lung cancer	0.0164	0.0353	CbGbCtD
Timolol—CYP2D6—Vinblastine—lung cancer	0.0155	0.0333	CbGbCtD
Timolol—ABCB1—Cisplatin—lung cancer	0.0151	0.0324	CbGbCtD
Timolol—ABCB1—Etoposide—lung cancer	0.0148	0.0318	CbGbCtD
Timolol—ABCB1—Docetaxel—lung cancer	0.0136	0.0291	CbGbCtD
Timolol—ABCB1—Doxorubicin—lung cancer	0.0101	0.0217	CbGbCtD
Timolol—ABCB1—Methotrexate—lung cancer	0.00978	0.021	CbGbCtD
Timolol—CYP2D6—Doxorubicin—lung cancer	0.00952	0.0205	CbGbCtD
Timolol—Sweating—Methotrexate—lung cancer	0.000104	0.000468	CcSEcCtD
Timolol—Palpitations—Docetaxel—lung cancer	0.000104	0.000468	CcSEcCtD
Timolol—Feeling abnormal—Cisplatin—lung cancer	0.000104	0.000468	CcSEcCtD
Timolol—Paraesthesia—Etoposide—lung cancer	0.000104	0.000467	CcSEcCtD
Timolol—Loss of consciousness—Docetaxel—lung cancer	0.000104	0.000466	CcSEcCtD
Timolol—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000104	0.000465	CcSEcCtD
Timolol—Dyspnoea—Etoposide—lung cancer	0.000103	0.000464	CcSEcCtD
Timolol—Somnolence—Etoposide—lung cancer	0.000103	0.000463	CcSEcCtD
Timolol—Cough—Docetaxel—lung cancer	0.000103	0.000462	CcSEcCtD
Timolol—Angina pectoris—Doxorubicin—lung cancer	0.000103	0.000462	CcSEcCtD
Timolol—Insomnia—Paclitaxel—lung cancer	0.000103	0.000461	CcSEcCtD
Timolol—Epistaxis—Methotrexate—lung cancer	0.000103	0.000461	CcSEcCtD
Timolol—Hypersensitivity—Irinotecan—lung cancer	0.000103	0.000461	CcSEcCtD
Timolol—Paraesthesia—Paclitaxel—lung cancer	0.000102	0.000458	CcSEcCtD
Timolol—Hypertension—Docetaxel—lung cancer	0.000102	0.000457	CcSEcCtD
Timolol—Agranulocytosis—Methotrexate—lung cancer	0.000102	0.000456	CcSEcCtD
Timolol—Dyspnoea—Paclitaxel—lung cancer	0.000101	0.000455	CcSEcCtD
Timolol—Somnolence—Paclitaxel—lung cancer	0.000101	0.000453	CcSEcCtD
Timolol—Decreased appetite—Etoposide—lung cancer	0.000101	0.000452	CcSEcCtD
Timolol—Myalgia—Docetaxel—lung cancer	0.000101	0.000451	CcSEcCtD
Timolol—Chest pain—Docetaxel—lung cancer	0.000101	0.000451	CcSEcCtD
Timolol—Arthralgia—Docetaxel—lung cancer	0.000101	0.000451	CcSEcCtD
Timolol—Nausea—Vinorelbine—lung cancer	0.0001	0.00045	CcSEcCtD
Timolol—Gastrointestinal disorder—Etoposide—lung cancer	0.0001	0.000449	CcSEcCtD
Timolol—Dyspepsia—Paclitaxel—lung cancer	0.0001	0.000449	CcSEcCtD
Timolol—Body temperature increased—Cisplatin—lung cancer	0.0001	0.000449	CcSEcCtD
Timolol—Asthenia—Irinotecan—lung cancer	0.0001	0.000449	CcSEcCtD
Timolol—Fatigue—Etoposide—lung cancer	0.0001	0.000449	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	9.99e-05	0.000448	CcSEcCtD
Timolol—Pain—Etoposide—lung cancer	9.92e-05	0.000445	CcSEcCtD
Timolol—Dysuria—Doxorubicin—lung cancer	9.89e-05	0.000444	CcSEcCtD
Timolol—Decreased appetite—Paclitaxel—lung cancer	9.89e-05	0.000443	CcSEcCtD
Timolol—Dry mouth—Docetaxel—lung cancer	9.84e-05	0.000441	CcSEcCtD
Timolol—Upper respiratory tract infection—Doxorubicin—lung cancer	9.83e-05	0.000441	CcSEcCtD
Timolol—Gastrointestinal disorder—Paclitaxel—lung cancer	9.82e-05	0.00044	CcSEcCtD
Timolol—Fatigue—Paclitaxel—lung cancer	9.81e-05	0.00044	CcSEcCtD
Timolol—Asthenia—Gemcitabine—lung cancer	9.75e-05	0.000437	CcSEcCtD
Timolol—Pain—Paclitaxel—lung cancer	9.73e-05	0.000436	CcSEcCtD
Timolol—Confusional state—Docetaxel—lung cancer	9.72e-05	0.000436	CcSEcCtD
Timolol—Oedema—Docetaxel—lung cancer	9.64e-05	0.000432	CcSEcCtD
Timolol—Anaphylactic shock—Docetaxel—lung cancer	9.64e-05	0.000432	CcSEcCtD
Timolol—Pruritus—Gemcitabine—lung cancer	9.61e-05	0.000431	CcSEcCtD
Timolol—Infection—Docetaxel—lung cancer	9.58e-05	0.00043	CcSEcCtD
Timolol—Weight decreased—Doxorubicin—lung cancer	9.57e-05	0.000429	CcSEcCtD
Timolol—Feeling abnormal—Etoposide—lung cancer	9.56e-05	0.000429	CcSEcCtD
Timolol—Hyperglycaemia—Doxorubicin—lung cancer	9.55e-05	0.000428	CcSEcCtD
Timolol—Diarrhoea—Irinotecan—lung cancer	9.54e-05	0.000428	CcSEcCtD
Timolol—Gastrointestinal pain—Etoposide—lung cancer	9.49e-05	0.000425	CcSEcCtD
Timolol—Shock—Docetaxel—lung cancer	9.49e-05	0.000425	CcSEcCtD
Timolol—Nervous system disorder—Docetaxel—lung cancer	9.46e-05	0.000424	CcSEcCtD
Timolol—Visual impairment—Methotrexate—lung cancer	9.43e-05	0.000423	CcSEcCtD
Timolol—Feeling abnormal—Paclitaxel—lung cancer	9.37e-05	0.00042	CcSEcCtD
Timolol—Skin disorder—Docetaxel—lung cancer	9.37e-05	0.00042	CcSEcCtD
Timolol—Hypersensitivity—Cisplatin—lung cancer	9.33e-05	0.000418	CcSEcCtD
Timolol—Gastrointestinal pain—Paclitaxel—lung cancer	9.3e-05	0.000417	CcSEcCtD
Timolol—Diarrhoea—Gemcitabine—lung cancer	9.3e-05	0.000417	CcSEcCtD
Timolol—Dizziness—Irinotecan—lung cancer	9.22e-05	0.000414	CcSEcCtD
Timolol—Urticaria—Etoposide—lung cancer	9.22e-05	0.000413	CcSEcCtD
Timolol—Anorexia—Docetaxel—lung cancer	9.19e-05	0.000412	CcSEcCtD
Timolol—Abdominal pain—Etoposide—lung cancer	9.17e-05	0.000411	CcSEcCtD
Timolol—Body temperature increased—Etoposide—lung cancer	9.17e-05	0.000411	CcSEcCtD
Timolol—Conjunctivitis—Doxorubicin—lung cancer	9.17e-05	0.000411	CcSEcCtD
Timolol—Eye disorder—Methotrexate—lung cancer	9.14e-05	0.00041	CcSEcCtD
Timolol—Tinnitus—Methotrexate—lung cancer	9.12e-05	0.000409	CcSEcCtD
Timolol—Asthenia—Cisplatin—lung cancer	9.09e-05	0.000407	CcSEcCtD
Timolol—Cardiac disorder—Methotrexate—lung cancer	9.08e-05	0.000407	CcSEcCtD
Timolol—Sweating—Doxorubicin—lung cancer	9.04e-05	0.000406	CcSEcCtD
Timolol—Urticaria—Paclitaxel—lung cancer	9.04e-05	0.000405	CcSEcCtD
Timolol—Hypotension—Docetaxel—lung cancer	9.01e-05	0.000404	CcSEcCtD
Timolol—Body temperature increased—Paclitaxel—lung cancer	8.99e-05	0.000403	CcSEcCtD
Timolol—Abdominal pain—Paclitaxel—lung cancer	8.99e-05	0.000403	CcSEcCtD
Timolol—Epistaxis—Doxorubicin—lung cancer	8.9e-05	0.000399	CcSEcCtD
Timolol—Angiopathy—Methotrexate—lung cancer	8.87e-05	0.000398	CcSEcCtD
Timolol—Vomiting—Irinotecan—lung cancer	8.87e-05	0.000398	CcSEcCtD
Timolol—Sinusitis—Doxorubicin—lung cancer	8.85e-05	0.000397	CcSEcCtD
Timolol—Immune system disorder—Methotrexate—lung cancer	8.83e-05	0.000396	CcSEcCtD
Timolol—Mediastinal disorder—Methotrexate—lung cancer	8.82e-05	0.000395	CcSEcCtD
Timolol—Agranulocytosis—Doxorubicin—lung cancer	8.8e-05	0.000395	CcSEcCtD
Timolol—Rash—Irinotecan—lung cancer	8.79e-05	0.000394	CcSEcCtD
Timolol—Dermatitis—Irinotecan—lung cancer	8.79e-05	0.000394	CcSEcCtD
Timolol—Musculoskeletal discomfort—Docetaxel—lung cancer	8.78e-05	0.000394	CcSEcCtD
Timolol—Headache—Irinotecan—lung cancer	8.74e-05	0.000392	CcSEcCtD
Timolol—Insomnia—Docetaxel—lung cancer	8.72e-05	0.000391	CcSEcCtD
Timolol—Diarrhoea—Cisplatin—lung cancer	8.66e-05	0.000389	CcSEcCtD
Timolol—Paraesthesia—Docetaxel—lung cancer	8.66e-05	0.000388	CcSEcCtD
Timolol—Alopecia—Methotrexate—lung cancer	8.64e-05	0.000388	CcSEcCtD
Timolol—Vomiting—Gemcitabine—lung cancer	8.64e-05	0.000387	CcSEcCtD
Timolol—Bradycardia—Doxorubicin—lung cancer	8.62e-05	0.000387	CcSEcCtD
Timolol—Dyspnoea—Docetaxel—lung cancer	8.6e-05	0.000385	CcSEcCtD
Timolol—Somnolence—Docetaxel—lung cancer	8.57e-05	0.000384	CcSEcCtD
Timolol—Mental disorder—Methotrexate—lung cancer	8.57e-05	0.000384	CcSEcCtD
Timolol—Rash—Gemcitabine—lung cancer	8.57e-05	0.000384	CcSEcCtD
Timolol—Dermatitis—Gemcitabine—lung cancer	8.56e-05	0.000384	CcSEcCtD
Timolol—Hypersensitivity—Etoposide—lung cancer	8.55e-05	0.000383	CcSEcCtD
Timolol—Erythema—Methotrexate—lung cancer	8.51e-05	0.000382	CcSEcCtD
Timolol—Malnutrition—Methotrexate—lung cancer	8.51e-05	0.000382	CcSEcCtD
Timolol—Headache—Gemcitabine—lung cancer	8.51e-05	0.000382	CcSEcCtD
Timolol—Rhinitis—Doxorubicin—lung cancer	8.49e-05	0.000381	CcSEcCtD
Timolol—Dyspepsia—Docetaxel—lung cancer	8.49e-05	0.000381	CcSEcCtD
Timolol—Decreased appetite—Docetaxel—lung cancer	8.38e-05	0.000376	CcSEcCtD
Timolol—Hypersensitivity—Paclitaxel—lung cancer	8.38e-05	0.000376	CcSEcCtD
Timolol—Oedema peripheral—Doxorubicin—lung cancer	8.34e-05	0.000374	CcSEcCtD
Timolol—Dysgeusia—Methotrexate—lung cancer	8.34e-05	0.000374	CcSEcCtD
Timolol—Gastrointestinal disorder—Docetaxel—lung cancer	8.32e-05	0.000373	CcSEcCtD
Timolol—Asthenia—Etoposide—lung cancer	8.32e-05	0.000373	CcSEcCtD
Timolol—Connective tissue disorder—Doxorubicin—lung cancer	8.32e-05	0.000373	CcSEcCtD
Timolol—Fatigue—Docetaxel—lung cancer	8.31e-05	0.000373	CcSEcCtD
Timolol—Nausea—Irinotecan—lung cancer	8.28e-05	0.000372	CcSEcCtD
Timolol—Pain—Docetaxel—lung cancer	8.24e-05	0.00037	CcSEcCtD
Timolol—Pruritus—Etoposide—lung cancer	8.21e-05	0.000368	CcSEcCtD
Timolol—Visual impairment—Doxorubicin—lung cancer	8.16e-05	0.000366	CcSEcCtD
Timolol—Asthenia—Paclitaxel—lung cancer	8.16e-05	0.000366	CcSEcCtD
Timolol—Nausea—Gemcitabine—lung cancer	8.07e-05	0.000362	CcSEcCtD
Timolol—Vomiting—Cisplatin—lung cancer	8.05e-05	0.000361	CcSEcCtD
Timolol—Pruritus—Paclitaxel—lung cancer	8.05e-05	0.000361	CcSEcCtD
Timolol—Vision blurred—Methotrexate—lung cancer	8.02e-05	0.00036	CcSEcCtD
Timolol—Rash—Cisplatin—lung cancer	7.98e-05	0.000358	CcSEcCtD
Timolol—Dermatitis—Cisplatin—lung cancer	7.98e-05	0.000358	CcSEcCtD
Timolol—Feeling abnormal—Docetaxel—lung cancer	7.95e-05	0.000356	CcSEcCtD
Timolol—Diarrhoea—Etoposide—lung cancer	7.94e-05	0.000356	CcSEcCtD
Timolol—Eye disorder—Doxorubicin—lung cancer	7.92e-05	0.000355	CcSEcCtD
Timolol—Tinnitus—Doxorubicin—lung cancer	7.9e-05	0.000354	CcSEcCtD
Timolol—Gastrointestinal pain—Docetaxel—lung cancer	7.88e-05	0.000354	CcSEcCtD
Timolol—Cardiac disorder—Doxorubicin—lung cancer	7.86e-05	0.000353	CcSEcCtD
Timolol—Diarrhoea—Paclitaxel—lung cancer	7.78e-05	0.000349	CcSEcCtD
Timolol—Angiopathy—Doxorubicin—lung cancer	7.68e-05	0.000345	CcSEcCtD
Timolol—Dizziness—Etoposide—lung cancer	7.67e-05	0.000344	CcSEcCtD
Timolol—Immune system disorder—Doxorubicin—lung cancer	7.65e-05	0.000343	CcSEcCtD
Timolol—Vertigo—Methotrexate—lung cancer	7.65e-05	0.000343	CcSEcCtD
Timolol—Mediastinal disorder—Doxorubicin—lung cancer	7.63e-05	0.000342	CcSEcCtD
Timolol—Abdominal pain—Docetaxel—lung cancer	7.62e-05	0.000342	CcSEcCtD
Timolol—Body temperature increased—Docetaxel—lung cancer	7.62e-05	0.000342	CcSEcCtD
Timolol—Arrhythmia—Doxorubicin—lung cancer	7.57e-05	0.000339	CcSEcCtD
Timolol—Dizziness—Paclitaxel—lung cancer	7.52e-05	0.000337	CcSEcCtD
Timolol—Nausea—Cisplatin—lung cancer	7.52e-05	0.000337	CcSEcCtD
Timolol—Alopecia—Doxorubicin—lung cancer	7.48e-05	0.000336	CcSEcCtD
Timolol—Cough—Methotrexate—lung cancer	7.43e-05	0.000333	CcSEcCtD
Timolol—Mental disorder—Doxorubicin—lung cancer	7.42e-05	0.000333	CcSEcCtD
Timolol—Vomiting—Etoposide—lung cancer	7.38e-05	0.000331	CcSEcCtD
Timolol—Malnutrition—Doxorubicin—lung cancer	7.37e-05	0.000331	CcSEcCtD
Timolol—Erythema—Doxorubicin—lung cancer	7.37e-05	0.000331	CcSEcCtD
Timolol—Rash—Etoposide—lung cancer	7.31e-05	0.000328	CcSEcCtD
Timolol—Dermatitis—Etoposide—lung cancer	7.31e-05	0.000328	CcSEcCtD
Timolol—Headache—Etoposide—lung cancer	7.27e-05	0.000326	CcSEcCtD
Timolol—Arthralgia—Methotrexate—lung cancer	7.25e-05	0.000325	CcSEcCtD
Timolol—Chest pain—Methotrexate—lung cancer	7.25e-05	0.000325	CcSEcCtD
Timolol—Myalgia—Methotrexate—lung cancer	7.25e-05	0.000325	CcSEcCtD
Timolol—Tension—Doxorubicin—lung cancer	7.24e-05	0.000324	CcSEcCtD
Timolol—Vomiting—Paclitaxel—lung cancer	7.23e-05	0.000324	CcSEcCtD
Timolol—Dysgeusia—Doxorubicin—lung cancer	7.22e-05	0.000324	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	7.2e-05	0.000323	CcSEcCtD
Timolol—Rash—Paclitaxel—lung cancer	7.17e-05	0.000322	CcSEcCtD
Timolol—Dermatitis—Paclitaxel—lung cancer	7.17e-05	0.000321	CcSEcCtD
Timolol—Discomfort—Methotrexate—lung cancer	7.16e-05	0.000321	CcSEcCtD
Timolol—Nervousness—Doxorubicin—lung cancer	7.16e-05	0.000321	CcSEcCtD
Timolol—Headache—Paclitaxel—lung cancer	7.13e-05	0.00032	CcSEcCtD
Timolol—Hypersensitivity—Docetaxel—lung cancer	7.1e-05	0.000319	CcSEcCtD
Timolol—Confusional state—Methotrexate—lung cancer	7.01e-05	0.000314	CcSEcCtD
Timolol—Anaphylactic shock—Methotrexate—lung cancer	6.95e-05	0.000312	CcSEcCtD
Timolol—Vision blurred—Doxorubicin—lung cancer	6.95e-05	0.000312	CcSEcCtD
Timolol—Asthenia—Docetaxel—lung cancer	6.92e-05	0.00031	CcSEcCtD
Timolol—Infection—Methotrexate—lung cancer	6.9e-05	0.00031	CcSEcCtD
Timolol—Nausea—Etoposide—lung cancer	6.89e-05	0.000309	CcSEcCtD
Timolol—Pruritus—Docetaxel—lung cancer	6.82e-05	0.000306	CcSEcCtD
Timolol—Nervous system disorder—Methotrexate—lung cancer	6.81e-05	0.000306	CcSEcCtD
Timolol—Nausea—Paclitaxel—lung cancer	6.76e-05	0.000303	CcSEcCtD
Timolol—Skin disorder—Methotrexate—lung cancer	6.75e-05	0.000303	CcSEcCtD
Timolol—Hyperhidrosis—Methotrexate—lung cancer	6.72e-05	0.000301	CcSEcCtD
Timolol—Vertigo—Doxorubicin—lung cancer	6.62e-05	0.000297	CcSEcCtD
Timolol—Anorexia—Methotrexate—lung cancer	6.62e-05	0.000297	CcSEcCtD
Timolol—Syncope—Doxorubicin—lung cancer	6.61e-05	0.000297	CcSEcCtD
Timolol—Diarrhoea—Docetaxel—lung cancer	6.6e-05	0.000296	CcSEcCtD
Timolol—Palpitations—Doxorubicin—lung cancer	6.52e-05	0.000292	CcSEcCtD
Timolol—Hypotension—Methotrexate—lung cancer	6.49e-05	0.000291	CcSEcCtD
Timolol—Loss of consciousness—Doxorubicin—lung cancer	6.48e-05	0.000291	CcSEcCtD
Timolol—Cough—Doxorubicin—lung cancer	6.43e-05	0.000289	CcSEcCtD
Timolol—Dizziness—Docetaxel—lung cancer	6.38e-05	0.000286	CcSEcCtD
Timolol—Hypertension—Doxorubicin—lung cancer	6.37e-05	0.000285	CcSEcCtD
Timolol—Musculoskeletal discomfort—Methotrexate—lung cancer	6.33e-05	0.000284	CcSEcCtD
Timolol—Insomnia—Methotrexate—lung cancer	6.29e-05	0.000282	CcSEcCtD
Timolol—Chest pain—Doxorubicin—lung cancer	6.28e-05	0.000281	CcSEcCtD
Timolol—Myalgia—Doxorubicin—lung cancer	6.28e-05	0.000281	CcSEcCtD
Timolol—Arthralgia—Doxorubicin—lung cancer	6.28e-05	0.000281	CcSEcCtD
Timolol—Anxiety—Doxorubicin—lung cancer	6.26e-05	0.000281	CcSEcCtD
Timolol—Paraesthesia—Methotrexate—lung cancer	6.24e-05	0.00028	CcSEcCtD
Timolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.23e-05	0.00028	CcSEcCtD
Timolol—Discomfort—Doxorubicin—lung cancer	6.2e-05	0.000278	CcSEcCtD
Timolol—Dyspnoea—Methotrexate—lung cancer	6.2e-05	0.000278	CcSEcCtD
Timolol—Somnolence—Methotrexate—lung cancer	6.18e-05	0.000277	CcSEcCtD
Timolol—Dry mouth—Doxorubicin—lung cancer	6.14e-05	0.000275	CcSEcCtD
Timolol—Vomiting—Docetaxel—lung cancer	6.13e-05	0.000275	CcSEcCtD
Timolol—Dyspepsia—Methotrexate—lung cancer	6.12e-05	0.000274	CcSEcCtD
Timolol—Rash—Docetaxel—lung cancer	6.08e-05	0.000273	CcSEcCtD
Timolol—Dermatitis—Docetaxel—lung cancer	6.07e-05	0.000272	CcSEcCtD
Timolol—Confusional state—Doxorubicin—lung cancer	6.07e-05	0.000272	CcSEcCtD
Timolol—Decreased appetite—Methotrexate—lung cancer	6.04e-05	0.000271	CcSEcCtD
Timolol—Headache—Docetaxel—lung cancer	6.04e-05	0.000271	CcSEcCtD
Timolol—Anaphylactic shock—Doxorubicin—lung cancer	6.02e-05	0.00027	CcSEcCtD
Timolol—Oedema—Doxorubicin—lung cancer	6.02e-05	0.00027	CcSEcCtD
Timolol—Gastrointestinal disorder—Methotrexate—lung cancer	6e-05	0.000269	CcSEcCtD
Timolol—Fatigue—Methotrexate—lung cancer	5.99e-05	0.000269	CcSEcCtD
Timolol—Infection—Doxorubicin—lung cancer	5.98e-05	0.000268	CcSEcCtD
Timolol—Pain—Methotrexate—lung cancer	5.94e-05	0.000266	CcSEcCtD
Timolol—Shock—Doxorubicin—lung cancer	5.92e-05	0.000265	CcSEcCtD
Timolol—Nervous system disorder—Doxorubicin—lung cancer	5.9e-05	0.000265	CcSEcCtD
Timolol—Skin disorder—Doxorubicin—lung cancer	5.84e-05	0.000262	CcSEcCtD
Timolol—Hyperhidrosis—Doxorubicin—lung cancer	5.82e-05	0.000261	CcSEcCtD
Timolol—Anorexia—Doxorubicin—lung cancer	5.74e-05	0.000257	CcSEcCtD
Timolol—Nausea—Docetaxel—lung cancer	5.73e-05	0.000257	CcSEcCtD
Timolol—Feeling abnormal—Methotrexate—lung cancer	5.73e-05	0.000257	CcSEcCtD
Timolol—Gastrointestinal pain—Methotrexate—lung cancer	5.68e-05	0.000255	CcSEcCtD
Timolol—Hypotension—Doxorubicin—lung cancer	5.62e-05	0.000252	CcSEcCtD
Timolol—Urticaria—Methotrexate—lung cancer	5.52e-05	0.000248	CcSEcCtD
Timolol—Abdominal pain—Methotrexate—lung cancer	5.49e-05	0.000246	CcSEcCtD
Timolol—Body temperature increased—Methotrexate—lung cancer	5.49e-05	0.000246	CcSEcCtD
Timolol—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.48e-05	0.000246	CcSEcCtD
Timolol—Insomnia—Doxorubicin—lung cancer	5.44e-05	0.000244	CcSEcCtD
Timolol—Paraesthesia—Doxorubicin—lung cancer	5.4e-05	0.000242	CcSEcCtD
Timolol—Dyspnoea—Doxorubicin—lung cancer	5.36e-05	0.000241	CcSEcCtD
Timolol—Somnolence—Doxorubicin—lung cancer	5.35e-05	0.00024	CcSEcCtD
Timolol—Dyspepsia—Doxorubicin—lung cancer	5.3e-05	0.000238	CcSEcCtD
Timolol—Decreased appetite—Doxorubicin—lung cancer	5.23e-05	0.000235	CcSEcCtD
Timolol—Gastrointestinal disorder—Doxorubicin—lung cancer	5.19e-05	0.000233	CcSEcCtD
Timolol—Fatigue—Doxorubicin—lung cancer	5.19e-05	0.000233	CcSEcCtD
Timolol—Pain—Doxorubicin—lung cancer	5.15e-05	0.000231	CcSEcCtD
Timolol—Hypersensitivity—Methotrexate—lung cancer	5.12e-05	0.00023	CcSEcCtD
Timolol—Asthenia—Methotrexate—lung cancer	4.99e-05	0.000224	CcSEcCtD
Timolol—Feeling abnormal—Doxorubicin—lung cancer	4.96e-05	0.000222	CcSEcCtD
Timolol—Gastrointestinal pain—Doxorubicin—lung cancer	4.92e-05	0.000221	CcSEcCtD
Timolol—Pruritus—Methotrexate—lung cancer	4.92e-05	0.00022	CcSEcCtD
Timolol—Urticaria—Doxorubicin—lung cancer	4.78e-05	0.000214	CcSEcCtD
Timolol—Abdominal pain—Doxorubicin—lung cancer	4.76e-05	0.000213	CcSEcCtD
Timolol—Body temperature increased—Doxorubicin—lung cancer	4.76e-05	0.000213	CcSEcCtD
Timolol—Diarrhoea—Methotrexate—lung cancer	4.75e-05	0.000213	CcSEcCtD
Timolol—Dizziness—Methotrexate—lung cancer	4.6e-05	0.000206	CcSEcCtD
Timolol—Hypersensitivity—Doxorubicin—lung cancer	4.43e-05	0.000199	CcSEcCtD
Timolol—Vomiting—Methotrexate—lung cancer	4.42e-05	0.000198	CcSEcCtD
Timolol—Rash—Methotrexate—lung cancer	4.38e-05	0.000196	CcSEcCtD
Timolol—Dermatitis—Methotrexate—lung cancer	4.38e-05	0.000196	CcSEcCtD
Timolol—Headache—Methotrexate—lung cancer	4.35e-05	0.000195	CcSEcCtD
Timolol—Asthenia—Doxorubicin—lung cancer	4.32e-05	0.000194	CcSEcCtD
Timolol—Pruritus—Doxorubicin—lung cancer	4.26e-05	0.000191	CcSEcCtD
Timolol—Nausea—Methotrexate—lung cancer	4.13e-05	0.000185	CcSEcCtD
Timolol—Diarrhoea—Doxorubicin—lung cancer	4.12e-05	0.000185	CcSEcCtD
Timolol—Dizziness—Doxorubicin—lung cancer	3.98e-05	0.000178	CcSEcCtD
Timolol—Vomiting—Doxorubicin—lung cancer	3.83e-05	0.000172	CcSEcCtD
Timolol—Rash—Doxorubicin—lung cancer	3.79e-05	0.00017	CcSEcCtD
Timolol—Dermatitis—Doxorubicin—lung cancer	3.79e-05	0.00017	CcSEcCtD
Timolol—Headache—Doxorubicin—lung cancer	3.77e-05	0.000169	CcSEcCtD
Timolol—Nausea—Doxorubicin—lung cancer	3.57e-05	0.00016	CcSEcCtD
Timolol—ABCB1—Metabolism—ENO2—lung cancer	1.25e-05	0.000204	CbGpPWpGaD
Timolol—ABCB1—Metabolism—HPGDS—lung cancer	1.25e-05	0.000204	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HES1—lung cancer	1.25e-05	0.000204	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IGF1R—lung cancer	1.25e-05	0.000203	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PPP2R1B—lung cancer	1.24e-05	0.000203	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTT1—lung cancer	1.24e-05	0.000203	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	1.24e-05	0.000202	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NCOA3—lung cancer	1.24e-05	0.000202	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—PIK3CA—lung cancer	1.23e-05	0.000201	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GCLC—lung cancer	1.23e-05	0.0002	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP2A6—lung cancer	1.23e-05	0.0002	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—RAF1—lung cancer	1.23e-05	0.0002	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MDM2—lung cancer	1.23e-05	0.0002	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.23e-05	0.0002	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HES1—lung cancer	1.22e-05	0.000199	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—RAF1—lung cancer	1.22e-05	0.000199	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTT1—lung cancer	1.21e-05	0.000198	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—IL2—lung cancer	1.21e-05	0.000197	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—ERBB2—lung cancer	1.21e-05	0.000197	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ABCG2—lung cancer	1.2e-05	0.000196	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ADCY1—lung cancer	1.2e-05	0.000196	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—RAF1—lung cancer	1.2e-05	0.000196	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GCLC—lung cancer	1.2e-05	0.000196	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP2A6—lung cancer	1.2e-05	0.000196	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	1.2e-05	0.000195	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MTOR—lung cancer	1.19e-05	0.000194	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CB—lung cancer	1.19e-05	0.000194	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—IL2—lung cancer	1.19e-05	0.000193	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—HPGDS—lung cancer	1.18e-05	0.000192	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ENO2—lung cancer	1.18e-05	0.000192	CbGpPWpGaD
Timolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.18e-05	0.000192	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.17e-05	0.000191	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	1.17e-05	0.000191	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ENO1—lung cancer	1.17e-05	0.00019	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.16e-05	0.000189	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	1.15e-05	0.000188	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.15e-05	0.000187	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CXCL8—lung cancer	1.15e-05	0.000187	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTT1—lung cancer	1.14e-05	0.000186	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ERBB3—lung cancer	1.14e-05	0.000186	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—HRAS—lung cancer	1.14e-05	0.000186	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ENO1—lung cancer	1.14e-05	0.000185	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.14e-05	0.000185	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP2A6—lung cancer	1.13e-05	0.000184	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GCLC—lung cancer	1.13e-05	0.000184	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	1.13e-05	0.000184	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ERBB3—lung cancer	1.12e-05	0.000182	CbGpPWpGaD
Timolol—ADRB3—GPCR downstream signaling—AKT1—lung cancer	1.11e-05	0.00018	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL2—lung cancer	1.1e-05	0.000179	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CASP3—lung cancer	1.1e-05	0.000179	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TERT—lung cancer	1.1e-05	0.000179	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL2—lung cancer	1.1e-05	0.000178	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—IL6—lung cancer	1.09e-05	0.000178	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL2—lung cancer	1.08e-05	0.000175	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TERT—lung cancer	1.07e-05	0.000175	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ENO1—lung cancer	1.07e-05	0.000175	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CCND1—lung cancer	1.07e-05	0.000174	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—JUN—lung cancer	1.07e-05	0.000174	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—FGFR1—lung cancer	1.07e-05	0.000173	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.06e-05	0.000173	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HIF1A—lung cancer	1.05e-05	0.000171	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP2E1—lung cancer	1.05e-05	0.00017	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—FGFR1—lung cancer	1.04e-05	0.00017	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MMP9—lung cancer	1.04e-05	0.000169	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—NQO1—lung cancer	1.03e-05	0.000168	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—CDKN1A—lung cancer	1.03e-05	0.000168	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PTEN—lung cancer	1.03e-05	0.000168	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HIF1A—lung cancer	1.03e-05	0.000167	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP2E1—lung cancer	1.02e-05	0.000166	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.01e-05	0.000165	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APOA1—lung cancer	1.01e-05	0.000165	CbGpPWpGaD
Timolol—ABCB1—Metabolism—NQO1—lung cancer	1.01e-05	0.000164	CbGpPWpGaD
Timolol—ADRB3—Signaling by GPCR—AKT1—lung cancer	1.01e-05	0.000164	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1e-05	0.000163	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KDR—lung cancer	1e-05	0.000163	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APOA1—lung cancer	9.9e-06	0.000161	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EP300—lung cancer	9.83e-06	0.00016	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KDR—lung cancer	9.81e-06	0.00016	CbGpPWpGaD
Timolol—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	9.63e-06	0.000157	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP2E1—lung cancer	9.62e-06	0.000157	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—SRC—lung cancer	9.56e-06	0.000156	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—NQO1—lung cancer	9.51e-06	0.000155	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—STK11—lung cancer	9.32e-06	0.000152	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—VEGFA—lung cancer	9.31e-06	0.000152	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	9.24e-06	0.000151	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—APC—lung cancer	9.24e-06	0.000151	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KIT—lung cancer	9.24e-06	0.000151	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—NRAS—lung cancer	9.24e-06	0.000151	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—STAT3—lung cancer	9.22e-06	0.00015	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—NRAS—lung cancer	9.2e-06	0.00015	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGF—lung cancer	9.13e-06	0.000149	CbGpPWpGaD
Timolol—ABCB1—Metabolism—STK11—lung cancer	9.1e-06	0.000148	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KIT—lung cancer	9.04e-06	0.000147	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	9.04e-06	0.000147	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—APC—lung cancer	9.04e-06	0.000147	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—NRAS—lung cancer	9.04e-06	0.000147	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGF—lung cancer	8.94e-06	0.000146	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	8.85e-06	0.000144	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MAPK3—lung cancer	8.81e-06	0.000143	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—POMC—lung cancer	8.8e-06	0.000143	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.75e-06	0.000143	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—BRAF—lung cancer	8.69e-06	0.000141	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	8.66e-06	0.000141	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTP1—lung cancer	8.63e-06	0.000141	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—POMC—lung cancer	8.61e-06	0.00014	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6R—lung cancer	8.58e-06	0.00014	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—STK11—lung cancer	8.58e-06	0.00014	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CREBBP—lung cancer	8.57e-06	0.00014	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—MYC—lung cancer	8.57e-06	0.00014	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—BRAF—lung cancer	8.5e-06	0.000138	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTP1—lung cancer	8.42e-06	0.000137	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—EGFR—lung cancer	8.42e-06	0.000137	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CAT—lung cancer	8.39e-06	0.000137	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6R—lung cancer	8.39e-06	0.000137	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CREBBP—lung cancer	8.38e-06	0.000137	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—EGFR—lung cancer	8.38e-06	0.000136	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.35e-06	0.000136	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—EGFR—lung cancer	8.24e-06	0.000134	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CAT—lung cancer	8.19e-06	0.000133	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	8.18e-06	0.000133	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ABCB1—lung cancer	8.17e-06	0.000133	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	8.12e-06	0.000132	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	8.05e-06	0.000131	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—TYMS—lung cancer	8.02e-06	0.000131	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	8e-06	0.00013	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—KRAS—lung cancer	7.95e-06	0.00013	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	7.95e-06	0.000129	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTP1—lung cancer	7.93e-06	0.000129	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—GSTM1—lung cancer	7.93e-06	0.000129	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—KRAS—lung cancer	7.92e-06	0.000129	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	7.87e-06	0.000128	CbGpPWpGaD
Timolol—ABCB1—Metabolism—TYMS—lung cancer	7.83e-06	0.000127	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—KRAS—lung cancer	7.78e-06	0.000127	CbGpPWpGaD
Timolol—ABCB1—Metabolism—GSTM1—lung cancer	7.74e-06	0.000126	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CAT—lung cancer	7.72e-06	0.000126	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CYP1A1—lung cancer	7.52e-06	0.000122	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ABCB1—lung cancer	7.51e-06	0.000122	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ERCC2—lung cancer	7.45e-06	0.000121	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—TYMS—lung cancer	7.38e-06	0.00012	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CYP1A1—lung cancer	7.34e-06	0.000119	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	7.31e-06	0.000119	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—GSTM1—lung cancer	7.29e-06	0.000119	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MDM2—lung cancer	7.28e-06	0.000119	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ERCC2—lung cancer	7.27e-06	0.000118	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—PIK3CA—lung cancer	7.27e-06	0.000118	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—RAF1—lung cancer	7.25e-06	0.000118	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—ERBB2—lung cancer	7.18e-06	0.000117	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	7.15e-06	0.000116	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MDM2—lung cancer	7.12e-06	0.000116	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—RAF1—lung cancer	7.09e-06	0.000116	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MTOR—lung cancer	7.08e-06	0.000115	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	7.08e-06	0.000115	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—TP53—lung cancer	7.04e-06	0.000115	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—ERBB2—lung cancer	7.02e-06	0.000114	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	6.93e-06	0.000113	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MTOR—lung cancer	6.93e-06	0.000113	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CYP1A1—lung cancer	6.91e-06	0.000113	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ERCC2—lung cancer	6.86e-06	0.000112	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CXCL8—lung cancer	6.8e-06	0.000111	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—HRAS—lung cancer	6.76e-06	0.00011	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—HRAS—lung cancer	6.73e-06	0.00011	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CXCL8—lung cancer	6.66e-06	0.000108	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—HRAS—lung cancer	6.61e-06	0.000108	CbGpPWpGaD
Timolol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	6.57e-06	0.000107	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CASP3—lung cancer	6.51e-06	0.000106	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL2—lung cancer	6.5e-06	0.000106	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—IL6—lung cancer	6.47e-06	0.000105	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—APOA1—lung cancer	6.45e-06	0.000105	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—IL6—lung cancer	6.44e-06	0.000105	CbGpPWpGaD
Timolol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	6.43e-06	0.000105	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CASP3—lung cancer	6.37e-06	0.000104	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL2—lung cancer	6.36e-06	0.000104	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CCND1—lung cancer	6.34e-06	0.000103	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—IL6—lung cancer	6.33e-06	0.000103	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—JUN—lung cancer	6.33e-06	0.000103	CbGpPWpGaD
Timolol—ABCB1—Metabolism—APOA1—lung cancer	6.29e-06	0.000103	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CCND1—lung cancer	6.2e-06	0.000101	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—JUN—lung cancer	6.19e-06	0.000101	CbGpPWpGaD
Timolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.17e-06	0.000101	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MMP9—lung cancer	6.15e-06	0.0001	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	6.13e-06	9.99e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PTEN—lung cancer	6.12e-06	9.97e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MMP9—lung cancer	6.02e-06	9.81e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	6e-06	9.77e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PTEN—lung cancer	5.99e-06	9.75e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling by GPCR—AKT1—lung cancer	5.97e-06	9.72e-05	CbGpPWpGaD
Timolol—ADRB3—Signaling Pathways—AKT1—lung cancer	5.94e-06	9.68e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—APOA1—lung cancer	5.93e-06	9.66e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CG—lung cancer	5.89e-06	9.59e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling by GPCR—AKT1—lung cancer	5.84e-06	9.51e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EP300—lung cancer	5.84e-06	9.5e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CG—lung cancer	5.75e-06	9.36e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EP300—lung cancer	5.71e-06	9.3e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—SRC—lung cancer	5.67e-06	9.24e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—POMC—lung cancer	5.6e-06	9.13e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—SRC—lung cancer	5.55e-06	9.04e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—VEGFA—lung cancer	5.53e-06	9e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—STAT3—lung cancer	5.47e-06	8.91e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—POMC—lung cancer	5.47e-06	8.91e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—NRAS—lung cancer	5.46e-06	8.89e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—CREBBP—lung cancer	5.46e-06	8.89e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CG—lung cancer	5.41e-06	8.82e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—VEGFA—lung cancer	5.41e-06	8.81e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—STAT3—lung cancer	5.35e-06	8.72e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—NRAS—lung cancer	5.34e-06	8.7e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—CREBBP—lung cancer	5.33e-06	8.68e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MAPK3—lung cancer	5.23e-06	8.52e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CD—lung cancer	5.17e-06	8.43e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—POMC—lung cancer	5.15e-06	8.39e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MAPK3—lung cancer	5.11e-06	8.33e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—ALB—lung cancer	5.11e-06	8.32e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—MYC—lung cancer	5.09e-06	8.28e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CD—lung cancer	5.05e-06	8.23e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—CREBBP—lung cancer	5.02e-06	8.18e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—ALB—lung cancer	4.99e-06	8.12e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—MYC—lung cancer	4.97e-06	8.1e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—EGFR—lung cancer	4.97e-06	8.1e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—EGFR—lung cancer	4.87e-06	7.92e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CD—lung cancer	4.76e-06	7.75e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—KRAS—lung cancer	4.7e-06	7.65e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—ALB—lung cancer	4.7e-06	7.65e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—KRAS—lung cancer	4.6e-06	7.49e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CB—lung cancer	4.51e-06	7.35e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTGS2—lung cancer	4.47e-06	7.28e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CB—lung cancer	4.4e-06	7.17e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTGS2—lung cancer	4.36e-06	7.1e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	4.32e-06	7.03e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	4.22e-06	6.88e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—TP53—lung cancer	4.18e-06	6.8e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CB—lung cancer	4.15e-06	6.76e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTGS2—lung cancer	4.11e-06	6.7e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—TP53—lung cancer	4.09e-06	6.65e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—HRAS—lung cancer	3.99e-06	6.5e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—HRAS—lung cancer	3.91e-06	6.36e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PTEN—lung cancer	3.9e-06	6.35e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—IL6—lung cancer	3.82e-06	6.23e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PTEN—lung cancer	3.8e-06	6.2e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—IL6—lung cancer	3.74e-06	6.09e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—EP300—lung cancer	3.72e-06	6.05e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—EP300—lung cancer	3.63e-06	5.91e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PTEN—lung cancer	3.58e-06	5.84e-05	CbGpPWpGaD
Timolol—ADRB1—Signaling Pathways—AKT1—lung cancer	3.53e-06	5.74e-05	CbGpPWpGaD
Timolol—ADRB2—Signaling Pathways—AKT1—lung cancer	3.45e-06	5.62e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—EP300—lung cancer	3.42e-06	5.57e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—PIK3CA—lung cancer	2.75e-06	4.48e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—PIK3CA—lung cancer	2.68e-06	4.37e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—PIK3CA—lung cancer	2.53e-06	4.12e-05	CbGpPWpGaD
Timolol—CYP2C19—Metabolism—AKT1—lung cancer	2.25e-06	3.66e-05	CbGpPWpGaD
Timolol—ABCB1—Metabolism—AKT1—lung cancer	2.19e-06	3.57e-05	CbGpPWpGaD
Timolol—CYP2D6—Metabolism—AKT1—lung cancer	2.07e-06	3.37e-05	CbGpPWpGaD
